These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 8853900

  • 1. Terminally differentiated skeletal myotubes are not confined to G0 but can enter G1 upon growth factor stimulation.
    Tiainen M, Pajalunga D, Ferrantelli F, Soddu S, Salvatori G, Sacchi A, Crescenzi M.
    Cell Growth Differ; 1996 Aug; 7(8):1039-50. PubMed ID: 8853900
    [Abstract] [Full Text] [Related]

  • 2. Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms.
    Tiainen M, Spitkovsky D, Jansen-Dürr P, Sacchi A, Crescenzi M.
    Mol Cell Biol; 1996 Oct; 16(10):5302-12. PubMed ID: 8816442
    [Abstract] [Full Text] [Related]

  • 3. MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes.
    Puri PL, Balsano C, Burgio VL, Chirillo P, Natoli G, Ricci L, Mattei E, Graessmann A, Levrero M.
    Oncogene; 1997 Mar 13; 14(10):1171-84. PubMed ID: 9121766
    [Abstract] [Full Text] [Related]

  • 4. E2F activates late-G1 events but cannot replace E1A in inducing S phase in terminally differentiated skeletal muscle cells.
    Pajalunga D, Tognozzi D, Tiainen M, D'Angelo M, Ferrantelli F, Helin K, Sacchi A, Crescenzi M.
    Oncogene; 1999 Sep 09; 18(36):5054-62. PubMed ID: 10490842
    [Abstract] [Full Text] [Related]

  • 5. SV40 large T antigen reinduces the cell cycle in terminally differentiated myotubes through inducing Cdk2, Cdc2, and their partner cyclins.
    Ohkubo Y, Kishimoto T, Nakata T, Yasuda H, Endo T.
    Exp Cell Res; 1994 Sep 09; 214(1):270-8. PubMed ID: 8082730
    [Abstract] [Full Text] [Related]

  • 6. The helix-loop-helix inhibitor of differentiation (ID) proteins induce post-mitotic terminally differentiated Sertoli cells to re-enter the cell cycle and proliferate.
    Chaudhary J, Sadler-Riggleman I, Ague JM, Skinner MK.
    Biol Reprod; 2005 May 09; 72(5):1205-17. PubMed ID: 15647457
    [Abstract] [Full Text] [Related]

  • 7. DNA replication is intrinsically hindered in terminally differentiated myotubes.
    Pajalunga D, Puggioni EM, Mazzola A, Leva V, Montecucco A, Crescenzi M.
    PLoS One; 2010 Jul 13; 5(7):e11559. PubMed ID: 20644635
    [Abstract] [Full Text] [Related]

  • 8. Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype.
    Endo T, Nadal-Ginard B.
    Mol Cell Biol; 1986 May 13; 6(5):1412-21. PubMed ID: 2431278
    [Abstract] [Full Text] [Related]

  • 9. Antagonistic actions of phorbol ester in mammalian G0-->G1-->S cell cycle transition.
    Faria M, Armelin HA.
    Cell Growth Differ; 1996 Jan 13; 7(1):75-81. PubMed ID: 8788035
    [Abstract] [Full Text] [Related]

  • 10. Subcellular compartmentalization of E2F family members is required for maintenance of the postmitotic state in terminally differentiated muscle.
    Gill RM, Hamel PA.
    J Cell Biol; 2000 Mar 20; 148(6):1187-201. PubMed ID: 10725332
    [Abstract] [Full Text] [Related]

  • 11. Mitotic cycle reactivation in terminally differentiated cells by adenovirus infection.
    Crescenzi M, Soddu S, Tatò F.
    J Cell Physiol; 1995 Jan 20; 162(1):26-35. PubMed ID: 7814449
    [Abstract] [Full Text] [Related]

  • 12. Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0/G1.
    Freytag SO.
    Mol Cell Biol; 1988 Apr 20; 8(4):1614-24. PubMed ID: 2454393
    [Abstract] [Full Text] [Related]

  • 13. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.
    Goya L, Maiyar AC, Ge Y, Firestone GL.
    Mol Endocrinol; 1993 Sep 20; 7(9):1121-32. PubMed ID: 8247014
    [Abstract] [Full Text] [Related]

  • 14. Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation.
    Puri PL, Cimino L, Fulco M, Zimmerman C, La Thangue NB, Giordano A, Graessmann A, Levrero M.
    Cancer Res; 1998 Apr 01; 58(7):1325-31. PubMed ID: 9537223
    [Abstract] [Full Text] [Related]

  • 15. p18INK4c and p27KIP1 are required for cell cycle arrest of differentiated myotubes.
    Myers TK, Andreuzza SE, Franklin DS.
    Exp Cell Res; 2004 Nov 01; 300(2):365-78. PubMed ID: 15475001
    [Abstract] [Full Text] [Related]

  • 16. Reversal of myogenic terminal differentiation by SV40 large T antigen results in mitosis and apoptosis.
    Endo T, Nadal-Ginard B.
    J Cell Sci; 1998 Apr 01; 111 ( Pt 8)():1081-93. PubMed ID: 9512504
    [Abstract] [Full Text] [Related]

  • 17. The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state.
    Smith EJ, Leone G, DeGregori J, Jakoi L, Nevins JR.
    Mol Cell Biol; 1996 Dec 01; 16(12):6965-76. PubMed ID: 8943352
    [Abstract] [Full Text] [Related]

  • 18. AG490 inhibits G1-S traverse in BALB/c-3T3 cells following either mitogenic stimulation or exogenous expression of E2F-1.
    Savell J, Ma Y, Morrow KS, Jove R, Olashaw N, Moseley PL, Cress WD, Wharton W.
    Mol Cancer Ther; 2004 Feb 01; 3(2):205-13. PubMed ID: 14985461
    [Abstract] [Full Text] [Related]

  • 19. Long-term fate of terminally differentiated skeletal muscle cells following E1A-initiated cell cycle reactivation.
    Latella L, Sacchi A, Crescenzi M.
    Cell Death Differ; 2000 Feb 01; 7(2):145-54. PubMed ID: 10713729
    [Abstract] [Full Text] [Related]

  • 20. Abrogation of p27Kip1 by cDNA antisense suppresses quiescence (G0 state) in fibroblasts.
    Rivard N, L'Allemain G, Bartek J, Pouysségur J.
    J Biol Chem; 1996 Aug 02; 271(31):18337-41. PubMed ID: 8702474
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.